CTKB
Companies
NASDAQ
Cytek Biosciences Inc.
Health Care
$3.07
-$3.42 (-52.70%)
Price Chart
Overview
About CTKB
Cytek Biosciences, Inc. is a life sciences technology company engaged in the provision of cell analysis tools by leveraging novel technical approaches.
Market Cap
$787.6M
Volume
2.7M
Avg. Volume
2.9M
P/E Ratio
61.166668
Dividend Yield
0.00%
Employees
615.0
Company Information
Latest News for CTKB
5 Most Cheapest Stocks In The Healthcare Sector: Bio-Techne, Mirati Therapeutics And More - Corcept Therapeutics (NASDAQ:CORT), Cytek Biosciences (NASDAQ:CTKB)
December 15, 2022
Investment in procedural medical devices is safer for valuation, says E Squared's Les Funtleyder
March 30, 2023
Cytek Biosciences, Inc. (CTKB) Reports Q1 Loss, Lags Revenue Estimates
May 8, 2025
Risk & Correlation Analysis
Market Correlation
1.03
Moderate Correlation
Volatility
High (0.70)
Relative to market
Macro Factor Sensitivities
Interest Rates
Low Sensitivity
Inflation
Medium Sensitivity
GDP Growth
Low Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, CTKB shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$787.6M
Volume2.7M
P/E Ratio61.17
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
November 6, 2024Related Securities
Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025